Our Story

Developing safer, more durable treatments
to improve the lives of patients

AltruBio is developing first-in-class immunomodulators to target diseases of the immune system. Our world-class global team brings a breadth of expertise in immunology and drug development to bring our biologic treatments to patients.  


Our Leadership

AltruBio’s senior management is built on a team of individuals possessing strong academic knowledge, high-level managerial experience and scientific expertise in a range of fields including life science, pharmacology, healthcare and immunology.

Judy Chou, Ph.D.

President and Chief Executive Officer

Jeroen Grasman

Chief Financial Officer

Jesse W. Hall, MD

Chief Medical Officer

Ping-Yang, Yeh, Ph.D.

President of Taiwan subsidiary

Gene Lee, Ph.D.

Chief Technical Officer

Shih-Yao Lin, MD., Ph.D.

Vice President of Research

Leewen Lin, Ph.D., LL.M.

Vice President of Legal Affairs

Simona Reed, Ph.D.

Vice President of Clinical Operations

Patrick Y. Yang, Ph.D.

Chairman of the Board

Sean P. Bohen, M.D., Ph.D.

Judy Chou, Ph.D.

President and Chief Executive Officer

John Doyle

Stephen G. Juelsgaard, D.V.M., J.D.

Gur Roshwalb, M.D.

Corsee Sanders, Ph.D.


Joseph B. Kirsner Professor of Medicine